Company news

Iqvia Holdings, Inc. (NYSE:IQV) news

Iqvia Holdings, Inc. news releases on 6ix. Latest, Oct 7, 2026: IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical…

Iqvia Holdings, Inc. (NYSE:IQV) news

Press releases & updates

IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes

IQVIA Launches IQVIA Explorer to Help Life Sciences Companies Make Better Commercial Decisions

IQVIA to Announce Third-Quarter 2026 Results on October 27, 2026

IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster

IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare

IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year

IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group

IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery

IQVIA Reports Second-Quarter 2026 Results

IQVIA's Dr. Cynthia Verst Testifies Before Congressional Subcommittee on More Efficient Path to Early Clinical Development in the United States

IQVIA to Announce Second-Quarter 2026 Results on July 28, 2026

New late-breaking data reinforces IQIRVO®’s impact on ALP, fatigue and pruritus in PBC

IQVIA CEO to Speak at Jefferies Global Healthcare Conference

IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities

Healthcare Data Monetization Research Report 2026

IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization

IQVIA CFO to Speak at Bank of America Health Care Conference 2026

IQVIA Reports First-Quarter 2026 Results

Pharmacovigilance and Drug Safety Software Market Report 2026 Featuring Profiles of IQVIA, Oracle Corporation, ArisGlobal, and RXLogix

IQVIA to Announce First-Quarter 2026 Results on May 5, 2026

IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences

IQVIA CFO to Speak at Barclays 28th Annual Global Healthcare Conference

IQVIA CEO to Speak at Leerink Partners 2026 Global Healthcare Conference

IQVIA Releases its 2025 Sustainability Report

IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities

IQVIA to Speak at Citi's 2026 Unplugged MedTech and Life Sciences Access Day

IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions

IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance

IQVIA and Boehringer Ingelheim announce strategic long-term global commercial data foundation transformation collaboration

IQVIA Named to the Fortune® World’s Most Admired Companies™ List, Ranked No. 1 in Its Sector for Fifth Consecutive Year

IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026

IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform

Dr. William G. Kaelin Jr. joins IQVIA Board of Directors

IQVIA Reports Third-Quarter 2025 Results

IQVIA CEO Ari Bousbib to Speak at UBS Global Healthcare Conference on November 11, 2025

IQVIA to Announce Third-Quarter 2025 Results on October 28, 2025

IQVIA Receives WCG Pinnacle Award for Excellence in Site Relationships

IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management

IQVIA Announces CFO Transition in Early 2026

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes

IQVIA Reports Second-Quarter 2025 Results

IQVIA to Announce Second-Quarter 2025 Results on July 22, 2025

IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement’

IQVIA Launches New AI Agents for Life Sciences and Healthcare

IQVIA Announces Pricing of Senior Notes

IQVIA Announces Offering of Senior Notes

Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF

IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials

IQVIA CFO Ron Bruehlman to speak at the Bank of America Annual Health Care Conference on May 13